Therapeutic equivalence of a low dose artemisinin formulation in falciparum malaria patients

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 2, 2003, Pages 193-198

  Wong, J W ^a   Yuen, K H ^a   Nagappan, S ^b   Shahul, W S ^b   David Ho, S S ^c   Gan, E K ^d   Toh, W T ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b General Hospital Tawau   (Malaysia)

^c Hovid Pte Ltd   (Malaysia)

^d SCHOOL OF PHYSICS   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; ARTEMISININ BETA CYCLODEXTRIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PARASITOLOGY; PLASMA CLEARANCE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANIMALS; ARTEMISININS; BETA-CYCLODEXTRINS; CYCLODEXTRINS; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PLASMODIUM FALCIPARUM; SESQUITERPENES; THERAPEUTIC EQUIVALENCY; TREATMENT OUTCOME;

EID: 0037331127     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/002235702441     Document Type: Article

References (20)

1. Alin, A. H., Ashton, M., Kihamia, C. M., Mtey, G. J. B., Björkman, A. (1996a) Clinical efficacy and pharmacokinetics of artemisinin monotherapy and in combination with mefloquine with falciparum malaria. Br. J. Clin. Pharmacol. 41: 587-592
2. Alin, A. H., Ashton, M., Kihamia, C. M., Mtey, G. J. B., Björkman, A. (1996b) Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malarial patients. Trans. R. Soc. Trop. Med. Hyg. 90: 61-65
3. Ashton, M., Nguyen, D. S., Nguyen, V. H., Toufigh, G., Trinh, N. H., Dinh, X. H., Nguyen, T. N., Le, D. C. (1998) Artemisinin kinetics and dynamics during oral and rectal treatment of uncomplicated malaria. Clin. Pharmacol. Ther. 63: 482-493
4. Chan, K. L., Yuen, K. H., Sunil, J., Peh, K. K., Toh, W. T. (1997) A high-performance liquid chromatography analysis of plasma artemisinin using a glassy carbon electrode for reductive electrochemical detection. Planta Med 63: 66-69
5. Cruickshank, R., Duguid, J. P., Marmion, B. P. (1977) Medical Microbiology. A Guide to the Laboratory Diagnosis and Control of Infections. Churchill Livingstone, New York
6. Dunnett, C. W., Gent, M. (1977) Significance testing to establish equivalence between treatment with special reference to data in the form of 2 × 2 tables. Biometrics 33: 593-602
7. Durrleman, S., Simon, R. (1990) Planning and monitoring of equivalence studies. Biometrics 46: 329-336
8. Jones, B., Jarvis, P., Lewis, J. A., Ebbutt, A. F. (1996) Trials to assess equivalence: The importance of rigorous methods. BMJ 313: 36-39
9. Kirk, R. E. (1968) Split-plot design - Factorial design with block treatment confounding. In: Experimental Design: Procedures for the Behavioural Sciences. Broddks/Cole Publishing Company, CA, pp 245-318
10. Klayman, D. L. (1985) Qinghaosu (Artemisinin): An antimalarial drug from China. Science 228: 1049-1055
11. Li, G. Q., Guo, X. B., Fu, L. C., Jian, H. X., Wang, X. H. (1994) Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. Trans. R. Soc. Trop. Med. Hyg. 88(Suppl.): 5-6
12. Luo, X. D., Shen, C. C. (1987) The chemistry, pharmacology and clinical applications of Qinghaosu (artemisinin) and its derivatives. Med. Res. Rev. 7: 29-52
13. Price, R. N., Nosten, F., Luxemberg, C., Ter Kuile, F. O., Paiphun, L., Chongsuphajaisiddhi, T., White, N. J. (1996) Effects of artemisinin derivatives on malaria transmissibility. Lancet 347: 1654-1658
14. Röhmel, J. (1998) Therapeutic equivalence investigations: Statistical considerations. Stat. Med. 17: 1703-1714
15. Titulaer, H. A. C., Zuidema, J., Lugt, C. B. (1991) Formulation and pharmacokinetics of artemisinin and its derivatives. Int. J. Pharm. 69: 83-92
16. White, N. J. (1994) Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives. Trans. R. Soc Trop. Med. Hyg. 8(Suppl. 1): 41-43.
17. Wong, J. W. (2001) Increased oral bioavailability of artemisinin via inclusion complexation with cyclodextrins. Ph.D. Thesis, University of Science, Malaysia
18. Wong, J. W., Yuen, K. H. (2001) Improved oral bioavailability of artemisinin through inclusion complexation with β- and γ-cyclodextrins. In. J. Pharm. 227: 177-185
19. World Health Organization (1994) The Role of Artemisinin and Its Derivatives in the Current Treatment of Malaria (1994-1995). Report of an Informal Consultation Convened by WHO in Geneva 27-29 September 1993. World Health Organization, Geneva, mimeographed document WHO/MAL/94.1067
20. World Health Organization (1998) The Use of Artemisinin and Its Derivatives as Anti-malarial Drugs. Reports of a Joint CTD/DMP/TDR Informal Consultation. World Health Organization, Geneva, Mimeographed document WHO/MAL/98.1086